Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Edesa Biotech, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
EDSA
Nasdaq
2836
www.edesabiotech.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Edesa Biotech, Inc.
EDSA: Advancing EB06 for the Treatment of Vitiligo…
- May 19th, 2025 7:54 am
Positive Signs As Multiple Insiders Buy Edesa Biotech Stock
- May 18th, 2025 6:51 am
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results
- May 14th, 2025 2:15 pm
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
- Apr 28th, 2025 2:30 pm
Edesa Biotech Announces Chief Financial Officer Transition
- Apr 4th, 2025 2:15 pm
EDSA: Raises $15 Million to Advance EB06…
- Mar 3rd, 2025 6:20 am
US Penny Stocks To Watch In February 2025
- Feb 14th, 2025 10:10 am
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- Feb 13th, 2025 5:00 am
EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo…
- Jan 22nd, 2025 4:23 am
Edesa Biotech And 2 Other Promising US Penny Stocks For Your Radar
- Dec 17th, 2024 10:08 am
Edesa Biotech Reports Fiscal Year 2024 Results
- Dec 13th, 2024 2:30 pm
Edesa Biotech’s Founder Makes Strategic Investment in the Company
- Oct 31st, 2024 6:15 am
Edesa Biotech Announces Upcoming Conference Schedule
- Oct 21st, 2024 6:15 am
EDSA: EB05 Selected for BARDA-Funded Study in ARDS…
- Aug 20th, 2024 6:25 am
Scroll